Matinas BioPharma Inc.

AMEX: MTNB · Real-Time Price · USD
2.31
0.66 (40.00%)
At close: Aug 15, 2025, 3:59 PM
2.42
4.99%
After-hours: Aug 15, 2025, 07:58 PM EDT

Matinas BioPharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.1 -2.05 -8.33 -10.03
PEG Ratio
0.02 -0.03 0.21 2.76
PS Ratio
n/a 42.86 34.00 6.37K
PB Ratio
0.33 2.44 2.96 4.04
P/FCF Ratio
-0.16 -3.03 -5.41 -13.71
P/OCF Ratio
-0.16 -3.07 -5.66 -13.94
OCF/S Ratio
n/a -13.94 -6.01 -456.71
Debt / Equity Ratio
0.38 0.18 0.11 0.09
Quick Ratio
3.01 5.93 8.06 11.73
Current Ratio
3.01 5.93 8.06 11.73
Asset Turnover
n/a 0.04 0.07 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-3.2 -1.19 -0.36 -0.4
Return on Assets
-1.92 -0.91 -0.29 -0.35
Return on Invested Capital
-2.13 -1.03 -0.37 -0.39
Dividend Yield
n/a n/a n/a 3.97
Payout Ratio
n/a n/a n/a -39.84
Gross Profit Margin
n/a -12.22 -4.23 -22.44
Net Profit Margin
n/a -20.93 -4.08 -635.21
Pretax Profit Margin
n/a -20.93 -6.59 -698.51
Operating Profit Margin
n/a -21.68 -7.71 -742.05
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -20.83 -7.6 -733.66